Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Continue Reading

City of Hope's Stephen J. Forman Joins Parker Institute for Cancer Immunotherapy

July 16, 2018 | Letisia Marquez

City of Hope’s CAR T research and treatment team is now an official member of the Parker Institute for Cancer Immunotherapy.

National Cancer Meeting Highlights the Expanding Role of Immunology

June 19, 2018 | Cary Presant, M.D.

At the annual 2018 meeting of the American Society of Clinical Oncology (ASCO) in Chicago, I was among the 40,000 oncologists impressed with how effective immunotherapy can be in some patients with cancer.

City of Hope to offer CAR T cell therapy for patients with the most common type of NHL

May 4, 2018 | Letisia Marquez

City of Hope recently announced that it is one of the first treatment centers certified in the United States to administer tisagenlecleucel CAR T cell therapy to adult patients with relapsed or refractory large B cell lymphoma.

Cheryl’s Story: CAR T Patient and Pioneer

April 30, 2018 | Letisia Marquez

Cheryl Wiers knew her cancer diagnosis happened for a reason, and for her, that reason could be her participation in a clinical trial using what is arguably the most promising cancer treatment — CAR T cell therapy.

CAR T Laboratory Research Yields Promising Prostate Cancer Results

April 17, 2018 | Letisia Marquez

City of Hope physicians have successfully treated blood cancers with chimeric antigen receptor (CAR) T cell therapy, and they are working to expand that therapy to patients with prostate cancer and other solid tumors.

First FDA-approved CAR T Therapy for Some Types of ALL to Be Offered at City of Hope

April 13, 2018 | Letisia Marquez

City of Hope recently announced that it is a certified treatment center to administer tisagenlecleucel CAR T cell therapy – the first CAR T cell therapy approved by the U.S. Food and Drug Administration – to patients.

Six Lessons from Behind the Scenes at City of Hope’s CAR T Cell Program

April 2, 2018 | Wayne Lewis

Often unrecognized are the countless folks who work in the spaces between the lab and the clinic — people responsible for doing everything from manufacturing CAR T cells to gaining federal approval for new trials.